Engineering naturally occurring CD7- T cells for the immunotherapy of hematological malignancies.
Freiwan A, Zoine JT, Crawford JC, Vaidya A, Schattgen SA, Myers JA, Patil SL, Khanlari M, Inaba H, Klco JM, Mullighan CG, Krenciute G, Chockley PJ, Naik S, Langfitt DM, Mamonkin M, Obeng EA, Thomas PG, Gottschalk S, Velasquez MP.
Freiwan A, et al. Among authors: schattgen sa.
Blood. 2022 Dec 22;140(25):2684-2696. doi: 10.1182/blood.2021015020.
Blood. 2022.
PMID: 35914226
Free PMC article.